AstraZeneca is dedicated to Oncology with a vision to eliminate cancer as a cause of death and aims to deliver six new molecular entities by 2025.
Base: $65,556.80 - $98,335.20; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program; Benefits: 401(k), paid vacation and holidays, paid leaves, medical, prescription drug, dental, and vision coverage
Must-have
Nice-to-have
Not specified